Stock Investors Sell Off Shares of Sanofi-Aventis, Down 1.3%

Print Share

Dec 28, 2012 (Market movers via COMTEX) -- Sanofi-Aventis (NYSE:SNY) is one of today's notable stocks in decline, down 1.3% to $46.87. The Dow is down 0.3% to 13,060 and the S&P is currently down 0.2% to 1,415.

Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

Over the past year, Sanofi-Aventis has traded in a range of $33.03 to $47.97 and is now at $46.87, 42% above that low. Over the past week, the 200-day moving average (MA) has gone up 0.3% while the 50-day MA has advanced 0.6%.

There is potential upside of 16.4% for shares of Sanofi-Aventis based on a current price of $46.87 and an average consensus analyst price target of $54.53. The stock should discover initial support at its 50-day moving average (MA) of $44.96 and subsequent support at its 200-day MA of $40.32.


Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit today.

Copyright, Comtex News Network, Inc. 2012

Free Stock Analysis From Zacks

Includes Zacks Long-Term Recommendation and Target Price

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.